Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
82 hedge funds and large institutions have $303M invested in Oxford Immunotec Global PLC Ordinary Shares in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 10 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 30
1% less funds holding
Funds holding: 83 → 82 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
22% less capital invested
Capital invested by funds: $390M → $303M (-$86.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$14M |
| 2 |
Man Group
London,
United Kingdom
|
+$2.63M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$2.52M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$1.98M |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$1.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$17.6M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$7.85M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.28M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$2.58M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.3M |
OXFD Hedge Fund Activity: Q4 2018 in Review
82 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2018, worth a combined $303M — down 22% from $390M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of OXFD and 9 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 32 added.
The largest buyer was First Light Asset Management, adding an estimated $14M. The largest seller was Deerfield Management, exiting entirely with an estimated $17.6M sold.
- 82 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2018, down from 83 in Q3 2018.
- Funds reported $303M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2018, down 22% quarter-over-quarter.
- 9 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2018 and 10 closed out, a net change of -1 holder.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2018 was First Light Asset Management, an estimated $14M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2018 was Deerfield Management, an estimated $17.6M sold.
Based on aggregated 13F filings for Q4 2018.